Ryan D. Maynard
2011
In 2011, Ryan D. Maynard earned a total compensation of $982.1K as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $247,200 |
|---|---|
| Option Awards | $322,082 |
| Salary | $412,000 |
| Other | $780 |
| Total | $982,062 |
Maynard received $412K in salary, accounting for 42% of the total pay in 2011.
Maynard also received $247.2K in non-equity incentive plan, $322.1K in option awards and $780 in other compensation.
Rankings
In 2011, Ryan D. Maynard's compensation ranked 5,719th out of 10,747 executives tracked by ExecPay. In other words, Maynard earned more than 46.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,719 out of 10,747 | 47th |
Division Manufacturing | 2,074 out of 3,960 | 48th |
Major group Chemicals And Allied Products | 457 out of 1,033 | 56th |
Industry group Drugs | 289 out of 781 | 63rd |
Industry Pharmaceutical Preparations | 227 out of 571 | 60th |
Source: SEC filing on April 8, 2014.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2011.
2011
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2011
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2011
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2011
Elliott Grossbard
Rigel Pharmaceuticals